Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jinnin

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Dermatology|June 11, 2009
Clinical and laboratory features of Japanese patients with scleroderma and telangiectasiaR Ashida, H Ihn, Y Mimura, et al.
The British Journal of Dermatology|October 20, 2004
Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosisY Mimura, H Ihn, M Jinnin, et al.
Rheumatology (Oxford, England)|November 10, 2005
Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosisY Asano, H Ihn, M Kubo, et al.
Dermatology (Basel, Switzerland)|November 28, 2013
Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximabS Yamada, T Makino, M Jinnin, et al.
The British Journal of Dermatology|April 21, 2005
Serum levels of anti-agalactosyl IgG antibodies in mixed connective tissue diseaseY Mimura, H Ihn, M Jinnin, et al.
Clinical and Experimental Rheumatology|September 8, 2006
Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized sclerodermaY Asano, H Ihn, M Kubo, et al.
The British Journal of Dermatology|November 6, 2009
Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosisM Jinnin, T Makino, I Kajihara, et al.
Rheumatology (Oxford, England)|November 8, 2002
Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung diseaseH Ihn, Y Asano, M Kubo, et al.
Rheumatology (Oxford, England)|March 17, 2005
A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusionY Asano, H Ihn, N Asashima, et al.
Bioscience Trends|September 15, 2011
The expression of HER-2 in extramammary Paget's diseaseS Masuguchi, M Jinnin, S Fukushima, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Dermatology|June 11, 2009
Clinical and laboratory features of Japanese patients with scleroderma and telangiectasiaR Ashida, H Ihn, Y Mimura, et al.
The British Journal of Dermatology|October 20, 2004
Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosisY Mimura, H Ihn, M Jinnin, et al.
Rheumatology (Oxford, England)|November 10, 2005
Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosisY Asano, H Ihn, M Kubo, et al.
Dermatology (Basel, Switzerland)|November 28, 2013
Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximabS Yamada, T Makino, M Jinnin, et al.
The British Journal of Dermatology|April 21, 2005
Serum levels of anti-agalactosyl IgG antibodies in mixed connective tissue diseaseY Mimura, H Ihn, M Jinnin, et al.
Clinical and Experimental Rheumatology|September 8, 2006
Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized sclerodermaY Asano, H Ihn, M Kubo, et al.
The British Journal of Dermatology|November 6, 2009
Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosisM Jinnin, T Makino, I Kajihara, et al.
Rheumatology (Oxford, England)|November 8, 2002
Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung diseaseH Ihn, Y Asano, M Kubo, et al.
Rheumatology (Oxford, England)|March 17, 2005
A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusionY Asano, H Ihn, N Asashima, et al.
Bioscience Trends|September 15, 2011
The expression of HER-2 in extramammary Paget's diseaseS Masuguchi, M Jinnin, S Fukushima, et al.
Pageof 5